| Sarah Breen, PA-C | |
|
222 N 7th St, Bismarck, ND 58501-4436 | |
| (701) 323-5422 | |
| Not Available |
| Full Name | Sarah Breen |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant |
| Experience | 7 Years |
| Location | 222 N 7th St, Bismarck, North Dakota |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1700386703 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363A00000X | Physician Assistant | (* (Not Available)) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sanford Medical Center Bismarck | Bismarck, ND | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Sanford Bismarck | 9739098575 | 448 |
News Archive
e-Therapeutics plc announces the start of the first clinical trial evaluating its compound ETS2101 as a treatment for cancer. The phase I trial is enrolling patients with primary brain cancer (glioma) or cancer that has spread to the brain from other sites.
A relatively simple electronic gadget could speed up HIV/AIDS diagnostics and improve accuracy particularly in parts of the world with very limited access to healthcare workers. The device is described in the International Journal of Biomedical Engineering and Technology.
DATATRAK International, Inc., a technology and services company focused on global eClinical solutions for the clinical trials industry, today announced the signing of an Enterprise Agreement for three new Phase III oncology studies with an existing client. These multi-center studies will be deployed utilizing the unified DATATRAK eClinical™ platform.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced that the U.S. Food and Drug Administration has assigned a Prescription Drug User Fee Act (PDUFA) action date of January 31, 2011 for the review of the Contrave® (naltrexone sustained release (SR)/bupropion SR) New Drug Application (NDA).
Government Ministers in Scotland are proposing a rethink on how drug addiction is both viewed and treated and want drug users' aspirations to be recognised.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sarah Breen, PA-C 5100 44th Ave S Apt 301, Fargo, ND 58104-3931 Ph: (701) 333-8670 | Sarah Breen, PA-C 222 N 7th St, Bismarck, ND 58501-4436 Ph: (701) 323-5422 |
News Archive
e-Therapeutics plc announces the start of the first clinical trial evaluating its compound ETS2101 as a treatment for cancer. The phase I trial is enrolling patients with primary brain cancer (glioma) or cancer that has spread to the brain from other sites.
A relatively simple electronic gadget could speed up HIV/AIDS diagnostics and improve accuracy particularly in parts of the world with very limited access to healthcare workers. The device is described in the International Journal of Biomedical Engineering and Technology.
DATATRAK International, Inc., a technology and services company focused on global eClinical solutions for the clinical trials industry, today announced the signing of an Enterprise Agreement for three new Phase III oncology studies with an existing client. These multi-center studies will be deployed utilizing the unified DATATRAK eClinical™ platform.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced that the U.S. Food and Drug Administration has assigned a Prescription Drug User Fee Act (PDUFA) action date of January 31, 2011 for the review of the Contrave® (naltrexone sustained release (SR)/bupropion SR) New Drug Application (NDA).
Government Ministers in Scotland are proposing a rethink on how drug addiction is both viewed and treated and want drug users' aspirations to be recognised.
› Verified 2 days ago
Burton J Mollman, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 4401 Coleman St Ste 107, Bismarck, ND 58503 Phone: 701-751-4340 Fax: 701-751-4340 | |
Djaninn Mae Shannon Mckibben, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 222 N 7th St, Bismarck, ND 58501 Phone: 701-323-6000 | |
Tracy L Vearrier, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 2520 N 7th St, Bismarck, ND 58503 Phone: 701-223-6595 | |
Samantha Mollman, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 310 N 10th St, Bismarck, ND 58501 Phone: 701-530-7500 | |
Kari A Thomas, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 300 N 7th St, Bismarck, ND 58501 Phone: 701-323-6000 | |
Stacie L Moritz, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1000 E Rosser Ave, Bismarck, ND 58501 Phone: 701-530-6000 Fax: 701-530-6430 | |
Emily M Stevenson, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 2603 E Broadway Ave, Bismarck, ND 58501 Phone: 701-323-5222 |